Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease An Observational Pilot Study
JOURNAL OF THORACIC ONCOLOGY, vol.4, no.12, pp.1480-1484, 2009 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 4 Issue: 12
- Publication Date: 2009
- Doi Number: 10.1097/jto.0b013e3181c0a7ff
- Journal Name: JOURNAL OF THORACIC ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1480-1484
- Keywords: F-18-fluorodeoxyglucose positron emission tomography-computed, tomography, Asbestos, Pleural disease, Malignant mesothelioma, Diffuse pleural thickening, Benign asbestos-related pleural effusions, PET, CT, DIAGNOSIS
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
Background: Several studies have already addressed the potential role of an increased fluorine 18 fluorodeoxyglucose (F-18 FDG) uptake in identification of pleural malignancy. In this pilot study, we investigate the role of F-18-FDG positron emission tomography/computed tomography (PET/CT) for differentiating asbestos-related benign pleural disease from malignant mesothelioma.